tioconazole has been researched along with loceryl in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cork, MJ; Haycox, A; Humphrey, KM | 1 |
| Sidou, F; Soto, P | 1 |
| Adjadj, L; Jäckel, A; Lambert, J; Marty, JP | 1 |
1 trial(s) available for tioconazole and loceryl
| Article | Year |
|---|---|
A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
Topics: Adult; Antifungal Agents; Ciclopirox; Female; Humans; Imidazoles; Lacquer; Male; Morpholines; Nails; Onychomycosis; Pyridones; Soaps; Thumb | 2004 |
2 other study(ies) available for tioconazole and loceryl
| Article | Year |
|---|---|
A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice.
Topics: Antifungal Agents; Cost-Benefit Analysis; England; Family Practice; Griseofulvin; Humans; Imidazoles; Morpholines; Naphthalenes; Onychomycosis; Referral and Consultation; Retrospective Studies; Terbinafine | 1998 |
Treatment costs of three nail lacquers used in onychomycosis.
Topics: Adult; Antifungal Agents; Ciclopirox; Drug Costs; Europe; Female; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Male; Morpholines; Onychomycosis; Pyridones | 2005 |